Translation & Spin-offs


FlexoSense is a spin-off from the National University of Singapore incorporated in 2016. The co-founders have experience in startups, R&D, business development, sales & marketing, operations, and finance.

The FlexoSense co-founders have had the privilege of being mentored by other startup entrepreneurs and key industry players. FlexoSense has been recognized through the JT Corporate Award and the Modern Aging Competition in Singapore. FlexoSense was one of the winners for IDTechEx Launchpad Berlin 2017.

The co-founders envision their sensors as enablers in sensing for healthcare devices, robotics, and consumer electronics.

FlexoSense uses patented technologies and advanced manufacturing methods to create flexible sensors. The flexible sensors, embedded within a skin-like elastomer, aim to enable digital health analytics with unparalleled ease and comfort.

Find out more HERE.


Privi Medical has developed a medical device to alleviate bleeding and pain caused by haemorrhoids, also known as piles.

This was in response to clinical need. While there are clinical interventions available to treat more severe hemorroids (grades 3-4), the choice of treatment options for less severe cases (grades 1-2) is very poor.

Patients with haemorrhoid symptoms often don’t want to go to the clinic or hospital and the treatments available over-the-counter are also mostly drugs or creams. The co-founders wanted to develop something safe and effective which patients can use at home to treat themselves.

The company, which was incorporated in 2015, was born out of the Singapore-Stanford Biodesign Fellowship – a year-long programme which aims to develop innovators in the medtech field.

Privi Medical’s three co-founders – Dr Dharmawan, Dr Benjamin Tee and Mr Prusothman Raja – are working to bring the product to market.

In January 2018, Privi Medical received FDA clearance for its InstaliefTM Hemorrhoids Treatment device.

Find out more HERE.